Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Bausch Health Companies stock | $20.56

Own Bausch Health Companies stock in just a few minutes.

Fact checked

Bausch Health Companies Inc is a drug manufacturers-specialty & generic business based in the US. Bausch Health Companies shares (BHC) are listed on the NYSE and all prices are listed in US Dollars. Bausch Health Companies employs 21,700 staff and has a trailing 12-month revenue of around USD$8 billion.

How to buy shares in Bausch Health Companies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Bausch Health Companies. Find the stock by name or ticker symbol: BHC. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Bausch Health Companies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$20.56, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Bausch Health Companies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Bausch Health Companies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Bausch Health Companies share price

Use our graph to track the performance of BHC stocks over time.

Bausch Health Companies shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$20.56
52-week rangeUSD$11.15 - USD$30.39
50-day moving average USD$19.7665
200-day moving average USD$17.9744
Wall St. target priceUSD$27.22
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-2.61

Buy Bausch Health Companies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Bausch Health Companies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bausch Health Companies price performance over time

Historical closes compared with the close of $20.56 from 2020-12-09

1 week (2021-01-11) -12.51%
1 month (2020-12-18) -0.82%
3 months (2020-10-16) 20.16%
6 months (2020-07-17) 13.84%
1 year (2020-01-17) -32.03%
2 years (2019-01-18) -10.96%
3 years (2018-01-18) 22.1
5 years (2016-01-15) 88.7

Is Bausch Health Companies under- or over-valued?

Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bausch Health Companies's EBITDA

Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$3.1 billion.

The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.

Bausch Health Companies financials

Revenue TTM USD$8 billion
Operating margin TTM 15.3%
Gross profit TTM USD$6.3 billion
Return on assets TTM 2.43%
Return on equity TTM -119.69%
Profit margin -23.92%
Book value $1.653
Market capitalisation USD$7.2 billion

TTM: trailing 12 months

Shorting Bausch Health Companies shares

There are currently 14.0 million Bausch Health Companies shares held short by investors – that's known as Bausch Health Companies's "short interest". This figure is 12.6% down from 16.0 million last month.

There are a few different ways that this level of interest in shorting Bausch Health Companies shares can be evaluated.

Bausch Health Companies's "short interest ratio" (SIR)

Bausch Health Companies's "short interest ratio" (SIR) is the quantity of Bausch Health Companies shares currently shorted divided by the average quantity of Bausch Health Companies shares traded daily (recently around 2.8 million). Bausch Health Companies's SIR currently stands at 4.92. In other words for every 100,000 Bausch Health Companies shares traded daily on the market, roughly 4920 shares are currently held short.

However Bausch Health Companies's short interest can also be evaluated against the total number of Bausch Health Companies shares, or, against the total number of tradable Bausch Health Companies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bausch Health Companies's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Bausch Health Companies shares in existence, roughly 40 shares are currently held short) or 0.0448% of the tradable shares (for every 100,000 tradable Bausch Health Companies shares, roughly 45 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bausch Health Companies.

Find out more about how you can short Bausch Health Companies stock.

Bausch Health Companies's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Bausch Health Companies.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Bausch Health Companies's total ESG risk score

Total ESG risk: 41.19

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Bausch Health Companies's overall score of 41.19 (as at 01/01/2019) is pretty weak – landing it in it in the 89th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Bausch Health Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Bausch Health Companies's environmental score

Environmental score: 3.36/100

Bausch Health Companies's environmental score of 3.36 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Bausch Health Companies's social score

Social score: 23.99/100

Bausch Health Companies's social score of 23.99 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Bausch Health Companies's governance score

Governance score: 16.84/100

Bausch Health Companies's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Bausch Health Companies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Bausch Health Companies's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Bausch Health Companies scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Bausch Health Companies has a damaged public profile.

Environmental, social, and governance (ESG) summary

Bausch Health Companies Inc was last rated for ESG on: 2019-01-01.

Total ESG score 41.19
Total ESG percentile 88.8
Environmental score 3.36
Environmental score percentile 4
Social score 23.99
Social score percentile 4
Governance score 16.84
Governance score percentile 4
Level of controversy 4

Bausch Health Companies share dividends

We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.

Have Bausch Health Companies's shares ever split?

Bausch Health Companies's shares were split on a 2:1 basis on 16 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bausch Health Companies shares which in turn could have impacted Bausch Health Companies's share price.

Bausch Health Companies share price volatility

Over the last 12 months, Bausch Health Companies's shares have ranged in value from as little as $11.15 up to $30.39. A popular way to gauge a stock's volatility is its "beta".

BHC.US volatility(beta: 1.41)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bausch Health Companies's is 1.41. This would suggest that Bausch Health Companies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Bausch Health Companies overview

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site